Comments to FDA: Health Claims; Calcium, Vitamin D, and Osteoporosis

Share page:

Comments | Mar 14, 2007

Docket Number:
2004P-0464

CHPA Dietary Supplements Committee members fully support the proposed changes to the labeling requirements for health claims regarding calcium and osteoporosis. These proposed changes amend the regulation authorizing health claims on the relationship between calcium and a reduced risk of osteoporosis.

Related Posts

hands in sterile gloves holding manufactured white tablets

Voluntary Codes and Guidelines

SIDI Protocol Version 3.0